Overview

Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®.

Status:
COMPLETED
Trial end date:
2024-05-05
Target enrollment:
Participant gender:
Summary
Study of comparative pharmacokinetics and biosimilarity of drugs containing semaglutide - GP40221 and Ozempic® in healthy volunteers.
Phase:
PHASE1
Details
Lead Sponsor:
Geropharm
Treatments:
semaglutide